Hynd; George
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hynd; George.The latest application filed is for "imidazolopyridine compounds for ire1 inhibition".
Company Profile
20.38.57
- Hynd; George - Cleveland OH
- Hynd; George - Harlow GB
- Hynd; George - Epping GB
- Hynd; George - Essex GB
- Hynd; George - Flex Meadow GB
Patent Activity
| Patent | Date |
|---|---|
| Imidazolopyridine Compounds For IRE1 Inhibition App 20220194945 - Keenan; Richard ; et al. | 2022-06-23 |
| Compounds useful as RET inhibitors Grant 11,352,361 - Jordan , et al. June 7, 2 | 2022-06-07 |
| Pyrazolopyridine Compounds For IRE1 Inhibition App 20220153734 - Keenan; Richard ; et al. | 2022-05-19 |
| Substituted azaindoline derivatives as NIK inhibitors Grant 11,236,084 - Hynd , et al. February 1, 2 | 2022-02-01 |
| Therapeutic Compounds App 20220002286 - Blaney; Emma L. ; et al. | 2022-01-06 |
| Cyanoindoline derivatives as NIK inhibitors Grant 11,186,589 - Stansfield , et al. November 30, 2 | 2021-11-30 |
| Substituted cyanoindoline derivatives as NIK inhibitors Grant 11,180,487 - Stansfield , et al. November 23, 2 | 2021-11-23 |
| Heteroaromatic derivatives as NIK inhibitors Grant 11,136,311 - Stansfield , et al. October 5, 2 | 2021-10-05 |
| New Substituted Azaindoline Derivatives As Nik Inhibitors App 20210188840 - HYND; George ; et al. | 2021-06-24 |
| Heterocyclic Compounds as RET Kinase Inhibitors App 20210155628 - Jordan; Allan Michael ; et al. | 2021-05-27 |
| 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors Grant 11,001,569 - Stansfield , et al. May 11, 2 | 2021-05-11 |
| New Substituted Cyanoindoline Derivatives As Nik Inhibitors App 20210087182 - STANSFIELD; Ian ; et al. | 2021-03-25 |
| Heterocyclic compounds as ret kinase inhibitors Grant 10,954,241 - Jordan , et al. March 23, 2 | 2021-03-23 |
| Heterocyclic Compounds as RET Kinase Inhibitors App 20210047334 - Jordan; Allan Michael ; et al. | 2021-02-18 |
| Cyanoindoline Derivatives As Nik Inhibitors App 20210032267 - Stansfield; Ian ; et al. | 2021-02-04 |
| Heterocyclic compounds as RET kinase inhibitors Grant 10,844,067 - Jordan , et al. November 24, 2 | 2020-11-24 |
| Compounds And Compositions For Ire1 Inhibition App 20200354367 - Keenan; Richard M. ; et al. | 2020-11-12 |
| Pyrazolopyrimidine derivatives as NIK inhibitors Grant 10,822,342 - Hynd , et al. November 3, 2 | 2020-11-03 |
| Compounds Useful as RET Inhibitors App 20200157107 - Jordan; Allan ; et al. | 2020-05-21 |
| Quinoline derivative in crystal form Grant 10,626,089 - Daley , et al. | 2020-04-21 |
| New 6-membered Heteroaromatic Substituted Cyanoindoline Derivatives As Nik Inhibitors App 20200109129 - STANSFIELD; Ian ; et al. | 2020-04-09 |
| Quinoline Derivative In Crystal Form App 20200017447 - Daley; Donald John ; et al. | 2020-01-16 |
| Heteroaromatic Derivatives As Nik Inhibitors App 20190359598 - Stansfield; Ian ; et al. | 2019-11-28 |
| Crystal Of Quinoline Derivative App 20190276405 - Daley; Donald John ; et al. | 2019-09-12 |
| Heterocyclic Compounds As Ret Kinase Inhibitors App 20190263819 - Jordan; Allan ; et al. | 2019-08-29 |
| Thienopyrimidine derivatives as NIK inhibitors Grant 10,323,045 - Hynd , et al. | 2019-06-18 |
| New Pyrazolopyrimidine Derivatives As Nik Inhibitors App 20190169198 - HYND; George ; et al. | 2019-06-06 |
| Cyanoindoline Derivatives As Nik Inhibitors App 20190119299 - Stansfield; Ian ; et al. | 2019-04-25 |
| Heterocyclic Compounds As Ret Kinase Inhibitors App 20190106425 - Jordan; Allan ; et al. | 2019-04-11 |
| Pyrazolopyrimidine derivatives as NIK inhibitors Grant 10,221,180 - Hynd , et al. | 2019-03-05 |
| New Thienopyrimidine Derivatives As Nik Inhibitors App 20180298032 - HYND; George ; et al. | 2018-10-18 |
| Compounds as NIK inhibitors Grant 10,005,776 - Hynd , et al. June 26, 2 | 2018-06-26 |
| 1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors Grant 10,005,773 - Hynd , et al. June 26, 2 | 2018-06-26 |
| 3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors Grant 9,981,963 - Hynd , et al. May 29, 2 | 2018-05-29 |
| Pyrazole derivatives as NIK inhibitors Grant 9,981,962 - Hynd , et al. May 29, 2 | 2018-05-29 |
| New Pyrazolopyrimidine Derivatives As Nik Inhibitors App 20170334915 - HYND; George ; et al. | 2017-11-23 |
| New Compounds As Nik Inhibitors App 20170334906 - HYND; George ; et al. | 2017-11-23 |
| New Pyrazole Derivatives As Nik Inhibitors App 20170334900 - HYND; George ; et al. | 2017-11-23 |
| 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer Grant 9,643,964 - Hynd , et al. May 9, 2 | 2017-05-09 |
| NEW 1-(4-PYRIMIDINYL)-1H-PYRROLO[3,2-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS App 20160257679 - HYND; George ; et al. | 2016-09-08 |
| NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS App 20160229851 - HYND; George ; et al. | 2016-08-11 |
| Pyrimidine cyclohexyl glucocorticoid receptor modulators Grant 9,321,736 - Clark , et al. April 26, 2 | 2016-04-26 |
| 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3-c]pyridine Derivatives As Nik Inhibitors For The Treatment Of Cancer App 20160075699 - HYND; George ; et al. | 2016-03-17 |
| Pyrimidine Cyclohexyl Glucocorticoid Receptor Modulators App 20150065532 - Clark; Robin ; et al. | 2015-03-05 |
| Pyrimidine cyclohexyl glucocorticoid receptor modulators Grant 8,906,917 - Clark , et al. December 9, 2 | 2014-12-09 |
| Pyrimidine Cyclohexyl Glucocorticoid Receptor Modulators App 20140162361 - Clark; Robin ; et al. | 2014-06-12 |
| Pyrimidine cyclohexyl glucocorticoid receptor modulators Grant 8,685,973 - Clark , et al. April 1, 2 | 2014-04-01 |
| Indoles And Their Therapeutic Use App 20130225617 - Hynd; George ; et al. | 2013-08-29 |
| Pyrimidine Cyclohexyl Glucocorticoid Receptor Modulators App 20130072486 - Clark; Robin ; et al. | 2013-03-21 |
| Indoles and their therapeutic use Grant 8,394,836 - Hynd , et al. March 12, 2 | 2013-03-12 |
| Quinolines and their therapeutic use Grant 8,394,830 - Montana , et al. March 12, 2 | 2013-03-12 |
| Quinolines and Their Therapeutic Use App 20120184579 - Montana; John Gary ; et al. | 2012-07-19 |
| Quinolines and their therapeutic use Grant 8,173,812 - Montana , et al. May 8, 2 | 2012-05-08 |
| EP.sub.2 receptor agonists Grant 8,080,567 - Oxford , et al. December 20, 2 | 2011-12-20 |
| Indoles and Their Therapeutic Use App 20110071175 - Hynd; George ; et al. | 2011-03-24 |
| Indoles Active on CRTH2 Receptor App 20110060026 - Hynd; George ; et al. | 2011-03-10 |
| EP.sub.4 receptor antagonists Grant 7,858,644 - Oxford , et al. December 28, 2 | 2010-12-28 |
| Quinolines and their therapeutic use Grant 7,858,640 - Cramp , et al. December 28, 2 | 2010-12-28 |
| EP2 Receptor Agonists App 20100261760 - Oxford; Alexander William ; et al. | 2010-10-14 |
| EP.sub.2 receptor agonists Grant 7,803,841 - Oxford , et al. September 28, 2 | 2010-09-28 |
| Quinoline Derivatives As Crth2 Receptor Ligands App 20100144786 - Cramp; Michael Colin ; et al. | 2010-06-10 |
| Quinolines and Their Therapeutic Use App 20100144787 - Montana; John Gary ; et al. | 2010-06-10 |
| Indolizine Acetic Acid Derivatives as CRTH2 Antagonists App 20100137300 - Hynd; George ; et al. | 2010-06-03 |
| Ep2 Receptor Agonists App 20100130556 - Oxford; Alexander William ; et al. | 2010-05-27 |
| Indolizineacetic Acids and Their Therapeutic Use as Ligands of the CRTH2 Receptor App 20100093751 - Hynd; George ; et al. | 2010-04-15 |
| EP2 receptor agonists Grant 7,662,839 - Oxford , et al. February 16, 2 | 2010-02-16 |
| Crth2 Antagonists App 20100010034 - Hynd; George ; et al. | 2010-01-14 |
| Ep2 Receptor Agonists App 20090298899 - Oxford; Alexander William ; et al. | 2009-12-03 |
| Thiazole Compounds and Their Use as PGD2 Antagonists App 20090221604 - Harris; Neil Victor ; et al. | 2009-09-03 |
| Furan derivatives as EP.sub.4 receptor antagonists Grant 7,569,602 - Clark , et al. August 4, 2 | 2009-08-04 |
| Indolizine Derivatives App 20090163534 - Hynd; George ; et al. | 2009-06-25 |
| Quinolines and Their Therapeutic Use App 20090156600 - Cramp; Michael Colin ; et al. | 2009-06-18 |
| Ep4 Receptor Antagonists App 20090143437 - Oxford; Alexander W. ; et al. | 2009-06-04 |
| EP.sub.4 receptor antagonists Grant 7,528,157 - Oxford , et al. May 5, 2 | 2009-05-05 |
| EP.sub.4 receptor antagonists Grant 7,507,754 - Oxford , et al. March 24, 2 | 2009-03-24 |
| 5-Ht2b Receptor Antagonists App 20090018150 - Borman; Richard Anthony ; et al. | 2009-01-15 |
| Ep4 Receptor Antagonists App 20080306117 - Clark; David Edward ; et al. | 2008-12-11 |
| Indolizine Derivatives as Ligands of the Crth2 Receptor App 20080306109 - Hynd; George ; et al. | 2008-12-11 |
| 5-HT.sub.2B receptor antagonists Grant 7,429,607 - Oxford , et al. September 30, 2 | 2008-09-30 |
| EP.sub.4 receptor antagonists Grant 7,417,068 - Clark , et al. August 26, 2 | 2008-08-26 |
| Ep2 Receptor Agonists App 20080119526 - Oxford; Alexander William ; et al. | 2008-05-22 |
| EP4 receptor antagonists App 20080039502 - Oxford; Alexander W. ; et al. | 2008-02-14 |
| EP2 receptor agonists Grant 7,326,732 - Oxford , et al. February 5, 2 | 2008-02-05 |
| Furan derivatives as ep4 receptor antagonists App 20070135503 - Clark; David Edward ; et al. | 2007-06-14 |
| Ep4 Receptor Antagonists App 20070123575 - Oxford; Alexander W. ; et al. | 2007-05-31 |
| EP.sub.4 receptor antagonists Grant 7,196,089 - Oxford , et al. March 27, 2 | 2007-03-27 |
| EP2 receptor agonists App 20050256170 - Oxford, Alexander William ; et al. | 2005-11-17 |
| 5-HT2B receptor antagonists App 20050176791 - Oxford, Alexander William ; et al. | 2005-08-11 |
| EP4 receptor antagonists App 20050124676 - Clark, David Edward ; et al. | 2005-06-09 |
| EP4 receptor antagonists App 20040192767 - Oxford, Alexander W. ; et al. | 2004-09-30 |
| 5-HT2B receptor antagonists App 20040010022 - Oxford, Alexander William ; et al. | 2004-01-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 